{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:10:37Z","timestamp":1784571037047,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016995","name":"Collaborative Research in Engineering Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejmech.2024.117234","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T02:51:20Z","timestamp":1735786280000},"page":"117234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Functional and structural polypharmacology of indazole-based privileged ligands to tackle the undruggability of membrane transporters"],"prefix":"10.1016","volume":"287","author":[{"given":"Katja","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Rafehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Latambale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Neif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"T\u00e4gl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nike Sophia","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab Nezafat","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Bakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouroud","family":"Ismail Al-Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"\u00d6zvegy-Laczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3031-3377","authenticated-orcid":false,"given":"Vigneshwaran","family":"Namasivayam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapil","family":"Juvale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven Marcel","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejmech.2024.117234_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/17425255.2021.1899159","article-title":"Renal and non-renal response of ABC and SLC transporters in chronic kidney disease","volume":"17","author":"Torres","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47798-x","article-title":"A Network of SLC and ABC Transporter and DME genes involved in remote sensing and signaling in the gut-liver-kidney axis","volume":"9","author":"Rosenthal","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ejmech.2024.117234_bib3","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.3390\/ijms22073742","article-title":"Disease-induced modulation of drug transporters at the blood-brain barrier level","volume":"22","author":"Al Rihani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117234_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrd4626","article-title":"SLC transporters as therapeutic targets: emerging opportunities","volume":"14","author":"Lin","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejmech.2024.117234_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biopha.2012.11.011","article-title":"Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.117234_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12986-020-00478-4","article-title":"The impact of ATP-binding cassette transporters on metabolic diseases","volume":"17","author":"Ye","year":"2020","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.ejmech.2024.117234_bib7","series-title":"Ichthyosis Fetalis, StatPearls, Treasure Island (FL)","author":"Elkhatib","year":"2023"},{"issue":"10","key":"10.1016\/j.ejmech.2024.117234_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104595","article-title":"Computational biology insights into genotype-clinical phenotype-protein phenotype relationships between novel SLC26A2 variants identified in inherited skeletal dysplasias","volume":"65","author":"Biji","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ejmech.2024.117234_bib9","first-page":"264","article-title":"Identification and characterization of novel MPC1 gene variants causing mitochondrial pyruvate carrier deficiency","author":"Jiang","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24123","article-title":"Christianson syndrome: a novel splicing variant of SLC9A6 causes exon skipping in a Chinese boy and a literature review","volume":"36","author":"Zhang","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"issue":"5","key":"10.1016\/j.ejmech.2024.117234_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15082","article-title":"H syndrome: a review of treatment options and a hypothesis of phenotypic variability","volume":"34","author":"Nofal","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117234_bib12","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.3390\/ijms22062858","article-title":"Structural and functional characterization of the ABCC6 transporter in hepatic cells: role on PXE, cancer therapy and drug resistance","volume":"22","author":"Bisaccia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117234_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100861","article-title":"Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations","volume":"79","author":"Cremers","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117234_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MOL.0000000000000669","article-title":"Tangier disease: Update for 2020","volume":"31","author":"Hooper","year":"2020","journal-title":"Curr. Opin. Lipidol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jdn.10003","article-title":"X-linked adrenoleukodystrophy: pathology, pathophysiology, diagnostic testing, newborn screening and therapies","volume":"80","author":"Turk","year":"2020","journal-title":"Int. J. Dev. Neurosci."},{"issue":"3","key":"10.1016\/j.ejmech.2024.117234_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ajhg.2012.01.018","article-title":"Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man","volume":"90","author":"Tuschl","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2024.117234_bib17","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.csbj.2021.05.018","article-title":"Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA)","volume":"19","author":"Namasivayam","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117234_bib18","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1021\/acs.jmedchem.9b01237","article-title":"The druggability of solute carriers","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117234_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1419110","article-title":"Medicinal polypharmacology-a scientific glossary of terminology and concepts","volume":"15","author":"Stefan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117234_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-024-03656-8","article-title":"Medicinal polypharmacology in the clinic - Translating the polypharmacolome into therapeutic benefit","author":"Rafehi","year":"2024","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2024.117234_bib21","article-title":"Medicinal polypharmacology: exploration and exploitation of the polypharmacolome in modern drug development","author":"Stefan","year":"2023","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41597-022-01506-z","article-title":"A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors","volume":"9","author":"Stefan","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.ejmech.2024.117234_bib23","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1016\/j.csbj.2021.11.035","article-title":"Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics","volume":"19","author":"Namasivayam","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117234_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-017-0506-8","article-title":"Renal drug transporters and drug interactions","volume":"56","author":"Ivanyuk","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117234_bib25","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117234_bib26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ijbiomac.2022.07.062","article-title":"Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics","volume":"217","author":"Namasivayam","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2024.117234_bib27","first-page":"33","article-title":"Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters","volume":"2","author":"Pahnke","year":"2021","journal-title":"Free Neuropathol"},{"issue":"5","key":"10.1016\/j.ejmech.2024.117234_bib28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/bioinformatics\/btab832","article-title":"Structural feature-driven pattern analysis for multitarget modulator landscapes","volume":"38","author":"Namasivayam","year":"2022","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.ejmech.2024.117234_bib29","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.3390\/nu12082306","article-title":"Inhibitory effects of quercetin and its main methyl, sulfate, and glucuronic acid conjugates on cytochrome P450 enzymes, and on OATP, BCRP and MRP2 transporters","volume":"12","author":"Mohos","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97160-3","article-title":"Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics","volume":"11","author":"Ambrus","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117234_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4155\/fmc.11.26","article-title":"Use of secondary structure element information in drug design: polypharmacology and conserved motifs in protein-ligand binding and protein-protein interfaces","volume":"3","author":"Koch","year":"2011","journal-title":"Future Med. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2024.117234_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/jsbi.2001.4335","article-title":"Fold change in evolution of protein structures","volume":"134","author":"Grishin","year":"2001","journal-title":"J. Struct. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117234_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1006\/jmbi.1998.2043","article-title":"Supersites within superfolds. Binding site similarity in the absence of homology","volume":"282","author":"Russell","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.117234_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400267","article-title":"Target repurposing unravels avermectins and derivatives as novel antibiotics inhibiting energy-coupling factor transporters (ECFTs)","author":"Haupenthal","year":"2024","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41597-024-03343-8","article-title":"Computer-aided pattern scoring - a multitarget dataset-driven workflow to predict ligands of orphan targets","volume":"11","author":"Stefan","year":"2024","journal-title":"Sci. Data"},{"issue":"17","key":"10.1016\/j.ejmech.2024.117234_bib36","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1021\/acs.jmedchem.4c00733","article-title":"Nonlipogenic ABCA1 inducers (NLAI) for Alzheimer's disease validated in a mouse model expressing human APOE3\/APOE4","volume":"67","author":"Velma","year":"2024","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.117234_bib37","doi-asserted-by":"crossref","first-page":"11904","DOI":"10.1021\/acs.jmedchem.1c00448","article-title":"Discovery of 5-2-[5-chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl-4-methoxypyridine-2-carboxylic acid, a highly selective in vivo useable chemical probe to dissect MCT4 Biology","volume":"64","author":"Heinrich","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117234_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112393","article-title":"Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: a review with structure-activity relationship insights","volume":"199","author":"Puri","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.117234_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"24","key":"10.1016\/j.ejmech.2024.117234_bib40","doi-asserted-by":"crossref","first-page":"10383","DOI":"10.1021\/jm501189p","article-title":"Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump","volume":"57","author":"Teijaro","year":"2014","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117234_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1124\/mol.63.2.351","article-title":"Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10)","volume":"63","author":"Chen","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117234_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101062","article-title":"The role of ABCC10\/MRP7 in anti-cancer drug resistance and beyond","volume":"73","author":"Chen","year":"2024","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib43","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acs.jmedchem.2c01612","article-title":"Indole derivatives as new structural class of potent and antiproliferative inhibitors of monocarboxylate transporter 1 (MCT1; SLC16A1)","volume":"66","author":"Puri","year":"2023","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2024.117234_bib44","first-page":"4073","article-title":"Recent advances in the chemistry of indazoles","author":"Snovydovych","year":"2008","journal-title":"Eur. J. Org Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2024.117234_bib45","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/molecules23112783","article-title":"Recent Advances in indazole-containing derivatives: synthesis and biological perspectives","volume":"23","author":"Zhang","year":"2018","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.ejmech.2024.117234_bib46","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.bmcl.2019.06.018","article-title":"The discovery of novel 3-aryl-indazole derivatives as peripherally restricted pan-Trk inhibitors for the treatment of pain","volume":"29","author":"Shirahashi","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.ejmech.2024.117234_bib47","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/pharmaceutics12111036","article-title":"Inhibitory effect of AB-PINACA, indazole carboxamide synthetic cannabinoid, on human major drug-metabolizing enzymes and transporters","volume":"12","author":"Park","year":"2020","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.ejmech.2024.117234_bib48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/bdd.2159","article-title":"Assessment of OATP transporter-mediated drug-drug interaction using physiologically-based pharmacokinetic (PBPK) modeling - a case example","volume":"39","author":"Chen","year":"2018","journal-title":"Biopharm. Drug Dispos."},{"issue":"11","key":"10.1016\/j.ejmech.2024.117234_bib49","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jcph.1261","article-title":"Effect of OATP1B1\/1B3 inhibitor GDC-0810 on the pharmacokinetics of pravastatin and coproporphyrin I\/III in healthy female subjects","volume":"58","author":"Liu","year":"2018","journal-title":"J. Clin. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejmech.2024.117234_bib50","doi-asserted-by":"crossref","first-page":"16807","DOI":"10.1021\/acs.jmedchem.4c01627","article-title":"Discovery and optimization of N-heteroaryl indazole LRRK2 inhibitors","volume":"67","author":"Logan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2024.117234_bib51","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1021\/jm300573d","article-title":"Discovery and pharmacological profile of new 1H-indazole-3-carboxamide and 2H-pyrrolo[3,4-c]quinoline derivatives as selective serotonin 4 receptor ligands","volume":"55","author":"Furlotti","year":"2012","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2024.117234_bib52","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/BJ20151120","article-title":"The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters","volume":"473","author":"Nancolas","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2024.117234_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133727","article-title":"Facile synthesis of new N1-alkylated 1H-indazole-3-carboxamide derivatives as potential anticancer agents: in vitro, ADMET prediction, and SAR studies","volume":"1269","author":"Puri","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"14","key":"10.1016\/j.ejmech.2024.117234_bib54","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1021\/acs.joc.9b01021","article-title":"2H-indazole tautomers stabilized by intra- and intermolecular hydrogen bonds","volume":"84","author":"Sigalov","year":"2019","journal-title":"J. Org. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2024.117234_bib55","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1055\/s-0040-1719917","article-title":"Selective N2-alkylation of 1H-indazoles and 1H-azaindazoles","volume":"54","author":"Clemens","year":"2022","journal-title":"Synthesis"},{"issue":"7","key":"10.1016\/j.ejmech.2024.117234_bib56","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/biology12070932","article-title":"ABC transporter C1 prevents dimethyl fumarate from targeting Alzheimer's disease","volume":"12","author":"M\u00f6hle","year":"2023","journal-title":"Biology"},{"issue":"6","key":"10.1016\/j.ejmech.2024.117234_bib57","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1021\/acs.jmedchem.0c02199","article-title":"C@PA: computer-aided pattern analysis to predict multitarget ABC transporter inhibitors","volume":"64","author":"Namasivayam","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117234_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113045","article-title":"Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site","volume":"212","author":"Silbermann","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2024.117234_bib59","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1021\/acs.jmedchem.0c00961","article-title":"Superior pyrimidine derivatives as selective ABCG2 inhibitors and broad-spectrum ABCB1, ABCC1, and ABCG2 antagonists","volume":"63","author":"Silbermann","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117234_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115769","article-title":"Tazemetostat synergistically combats multidrug resistance by the unique triple inhibition of ABCB1, ABCC1, and ABCG2 efflux transporters in vitro and ex vivo","volume":"216","author":"Budagaga","year":"2023","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117234_bib61","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1007\/s00204-022-03359-2","article-title":"Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters","volume":"96","author":"Morell","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2024.117234_bib62","article-title":"Cellular uptake of psychostimulants - are high- and low-Affinity organic cation transporters drug traffickers?","volume":"11","author":"Jensen","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.117234_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113136","article-title":"Interactions of resveratrol and its metabolites (resveratrol-3-sulfate, resveratrol-3-glucuronide, and dihydroresveratrol) with serum albumin, cytochrome P450 enzymes, and OATP transporters","volume":"151","author":"Poor","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117234_bib64","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1021\/acs.molpharmaceut.3c00691","article-title":"Stereoselective inhibition of high- and low-affinity organic cation transporters","volume":"20","author":"Gebauer","year":"2023","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117234_bib65","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/febs.15156","article-title":"A novel fluorescence-based functional assay for human OATP1A2 and OATP1C1 identifies interaction between third-generation P-gp inhibitors and OATP1A2","volume":"287","author":"Bakos","year":"2020","journal-title":"FEBS J."},{"issue":"21","key":"10.1016\/j.ejmech.2024.117234_bib66","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1021\/acs.jmedchem.7b00788","article-title":"9-Deazapurines as broad-spectrum inhibitors of the ABC transport proteins P-glycoprotein, multidrug resistance-associated protein 1, and breast cancer resistance protein","volume":"60","author":"Stefan","year":"2017","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117234_bib67","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2020.11.043","article-title":"Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1021\/acs.jmedchem.1c01272","article-title":"Discovery and characterization of potent dual P-glycoprotein and CYP3A4 inhibitors: design, synthesis, cryo-EM analysis, and biological evaluations","volume":"65","author":"Urgaonkar","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2024.117234_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220012120","article-title":"A macrocyclic peptide inhibitor traps MRP1 in a catalytically incompetent conformation","volume":"120","author":"Pietz","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib70","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213437120","article-title":"Differential dynamics and direct interaction of bound ligands with lipids in multidrug transporter ABCG2","volume":"120","author":"Rasouli","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117234_bib71","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41422-023-00870-8","article-title":"Cryo-EM structures of human organic anion transporting polypeptide OATP1B1","volume":"33","author":"Shan","year":"2023","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib72","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1038\/s41467-023-41552-8","article-title":"Structure of human drug transporters OATP1B1 and OATP1B3","volume":"14","author":"Ciuta","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ejmech.2024.117234_bib73","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41594-023-01017-4","article-title":"Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2","volume":"30","author":"Suo","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib74","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1038\/s41467-022-34284-8","article-title":"Structural basis of organic cation transporter-3 inhibition","volume":"13","author":"Khanppnavar","year":"2022","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejmech.2024.117234_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168038","article-title":"Activity and structural dynamics of human ABCA1 in a lipid membrane","volume":"435","author":"Plummer-Medeiros","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.117234_bib76","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/mol.118.114314","article-title":"Organic anion transporting polypeptides: emerging roles in cancer pharmacology","volume":"95","author":"Schulte","year":"2019","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117234_bib77","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/03602532.2019.1670204","article-title":"The human organic cation transporter OCT1 and its role as a target for drug responses","volume":"51","author":"Brosseau","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejmech.2024.117234_bib78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2407-12-109","article-title":"Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance","volume":"12","author":"Heise","year":"2012","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.ejmech.2024.117234_bib79","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/mp.2011.87","article-title":"Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response","volume":"17","author":"Bacq","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117234_bib80","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00702-009-0205-1","article-title":"Decreased anxiety in mice lacking the organic cation transporter 3","volume":"116","author":"Wultsch","year":"2009","journal-title":"J. Neural. Transm."},{"issue":"22","key":"10.1016\/j.ejmech.2024.117234_bib81","doi-asserted-by":"crossref","first-page":"13020","DOI":"10.1021\/acs.chemrev.4c00423","article-title":"Tackling undruggable targets with designer peptidomimetics and synthetic biologics","volume":"124","author":"Swenson","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117234_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100294","article-title":"Base and metal free true recyclable medium for Knoevenagel condensation reaction in SDS-ionic liquid-aqueous miceller composite system","volume":"4","author":"Chakraborty","year":"2022","journal-title":"Results in Chemistry"},{"key":"10.1016\/j.ejmech.2024.117234_bib83","article-title":"Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2","volume":"197","author":"Gebauer","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib84","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/s41598-018-20815-1","article-title":"Identification of novel cell-impermeant fluorescent substrates for testing the function and drug interaction of organic anion-transporting polypeptides, OATP1B1\/1B3 and 2B1","volume":"8","author":"Patik","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.117234_bib85","article-title":"Establishment and characterization of a novel multidrug resistant human ovarian cancer cell line with heterogenous MRP7 overexpression","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117234_bib86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2024.117234_bib87","unstructured":"Molecular Operating Environment (MOE), version 2022.02, Chemical Computing Group: Montreal, Quebec, Canada."},{"issue":"12","key":"10.1016\/j.ejmech.2024.117234_bib88","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F","article-title":"How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?","volume":"21","author":"Wang","year":"2000","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.117234_bib89","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.117234_bib90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1747-0285.2007.00588.x","article-title":"pso@autodock: a fast flexible molecular docking program based on swarm intelligence","volume":"70","author":"Namasivayam","year":"2007","journal-title":"Chem. Biol. Drug Des."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424011164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424011164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:58:37Z","timestamp":1759298317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424011164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":90,"alternative-id":["S0223523424011164"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117234","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional and structural polypharmacology of indazole-based privileged ligands to tackle the undruggability of membrane transporters","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117234"}}